Core Viewpoint - The company focuses on rapidly developing treatment areas such as medical aesthetics, wound care, ophthalmology, orthopedics, and surgery, accelerating the transformation of innovative results [2] Group 1: Product Development - The company has received approvals for high-end hyaluronic acid products "Haimi" and "Haimi Moon White," as well as various mid-range and high-end artificial lenses and high-permeability corneal shaping lenses [2] - The company is expanding its product line in medical aesthetics and ophthalmology, with several key R&D projects underway, including painless cross-linked hyaluronic acid, medical cross-linked chitosan gel, enhanced water-light injection agents, and linear precision cross-linked water-light injection agents [2] Group 2: R&D Focus - Ongoing R&D projects include hydrophilic continuous vision artificial lenses, hydrophobic mold-injected extended depth of focus artificial lenses, intraocular filling biological gels, aqueous permeable PRL, high-permeability scleral lenses, and new high-permeability (DK180) corneal shaping lenses [2]